COVID-19: Why does disease severity vary among individuals?
- PMID: 33713961
- PMCID: PMC7934673
- DOI: 10.1016/j.rmed.2021.106356
COVID-19: Why does disease severity vary among individuals?
Abstract
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is responsible for the current pandemic, coronavirus disease 2019 (COVID-19). While all people are susceptible to the SARS-CoV-2 infection, the nature and severity of the disease vary significantly among individuals and populations. Importantly, reported disease burdens and case fatality rates differ considerably from country to country. There are, however, still uncertainties about the severity of the disease among individuals or the reason behind a more severe disease in some cases. There is a strong possibility that the severity of this disease depends on a complicated interaction between the host, virus, and environment, which leads to different clinical outcomes. The objective of this article is to point out the essential influential factors related to the host, virus, and environment affecting the clinical outcome of COVID-19.
Keywords: COVID-19; Environment; Host; SARS-CoV-2; Virus.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures

Similar articles
-
Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019.Curr Opin Allergy Clin Immunol. 2021 Apr 1;21(2):182-187. doi: 10.1097/ACI.0000000000000720. Curr Opin Allergy Clin Immunol. 2021. PMID: 33399389 Review.
-
COVID-19 pandemic: Insights into genetic susceptibility to SARS-CoV-2 and host genes implications on virus spread, disease severity and outcomes.Hum Antibodies. 2022;30(1):1-14. doi: 10.3233/HAB-211506. Hum Antibodies. 2022. PMID: 34864654 Review.
-
Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.OMICS. 2020 Nov;24(11):634-644. doi: 10.1089/omi.2020.0131. Epub 2020 Sep 16. OMICS. 2020. PMID: 32940573 Review.
-
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.Lancet Infect Dis. 2020 Sep;20(9):e238-e244. doi: 10.1016/S1473-3099(20)30484-9. Epub 2020 Jul 3. Lancet Infect Dis. 2020. PMID: 32628905 Free PMC article. Review.
-
Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study.Eur J Cancer. 2021 Apr;147:120-127. doi: 10.1016/j.ejca.2021.01.021. Epub 2021 Feb 3. Eur J Cancer. 2021. PMID: 33647547 Free PMC article.
Cited by
-
Association between ABO blood groups and the risk of infection with SARS-CoV-2 in Iraq.J Int Med Res. 2022 Nov;50(11):3000605221133147. doi: 10.1177/03000605221133147. J Int Med Res. 2022. PMID: 36329597 Free PMC article.
-
COVID-19 in Pediatrics: Demographic, Clinical, Laboratory, and Radiological Characteristics of Infected Patients With SARS-CoV-2.Front Pediatr. 2022 Jan 13;9:808187. doi: 10.3389/fped.2021.808187. eCollection 2021. Front Pediatr. 2022. PMID: 35096716 Free PMC article.
-
The Dark Side of Nosocomial Infections in Critically Ill COVID-19 Patients.Life (Basel). 2023 Jun 17;13(6):1408. doi: 10.3390/life13061408. Life (Basel). 2023. PMID: 37374189 Free PMC article. Review.
-
Computational network biology analysis revealed COVID-19 severity markers: Molecular interplay between HLA-II with CIITA.PLoS One. 2025 Mar 31;20(3):e0319205. doi: 10.1371/journal.pone.0319205. eCollection 2025. PLoS One. 2025. PMID: 40163554 Free PMC article.
-
A Longitudinal Analysis of SARS-CoV-2 Antibody Responses Among People With HIV.Front Med (Lausanne). 2022 Mar 7;9:768138. doi: 10.3389/fmed.2022.768138. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35330585 Free PMC article.
References
-
- Teymoori-Rad M., Samadizadeh S., Tabarraei A., Moradi A., Shahbaz M.B., Tahamtan A. Ten challenging questions about SARS-CoV-2 and COVID-19. Expet Rev. Respir. Med. 2020;14(9):881–888. - PubMed
-
- Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 7 cases from the Chinese center for disease control and prevention. Jama. 2020;323(13):1239–1242. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous